MSB 10.4% $1.49 mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-113

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,224 Posts.
    lightbulb Created with Sketch. 44
    It would seem to me that in the current climate where vaccines are being hailed one minute and dismissed the next that any Covid trial which is under 50% complete would be more more difficult to hail as a breakthrough.
    Therefore going to at least 60% tested before the trial could be halted for efficacy would seem better for all parties MSB, FDA, and most importantly the sick.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.